These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
585 related items for PubMed ID: 18035771
1. The role of thalidomide in the management of erythema nodosum leprosum. Walker SL, Waters MF, Lockwood DN. Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771 [Abstract] [Full Text] [Related]
2. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study]. de Carsalade GY, Achirafi A, Flageul B. Acta Leprol; 2003 Sep; 12(3):117-22. PubMed ID: 15040702 [Abstract] [Full Text] [Related]
3. Pentoxifylline in the treatment of erythema nodosum leprosum. De Carsalade GY, Achirafi A, Flageul B. J Dermatol; 2003 Jan; 30(1):64-8. PubMed ID: 12598712 [Abstract] [Full Text] [Related]
4. Erythema nodosum leprosum in Nepal: a retrospective study of clinical features and response to treatment with prednisolone or thalidomide. Feuth M, Brandsma JW, Faber WR, Bhattarai B, Feuth T, Anderson AM. Lepr Rev; 2008 Sep; 79(3):254-69. PubMed ID: 19009975 [Abstract] [Full Text] [Related]
5. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum. Verma KK, Srivastava P, Minz A, Verma K. Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003 [Abstract] [Full Text] [Related]
6. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India. Upputuri B, Pallapati MS, Tarwater P, Srikantam A. PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210 [Abstract] [Full Text] [Related]
11. Erythema Nodosum Leprosum: Update and challenges on the treatment of a neglected condition. Costa PDSS, Fraga LR, Kowalski TW, Daxbacher ELR, Schuler-Faccini L, Vianna FSL. Acta Trop; 2018 Jul; 183():134-141. PubMed ID: 29474830 [Abstract] [Full Text] [Related]
12. A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum. Villahermosa LG, Fajardo TT, Abalos RM, Balagon MV, Tan EV, Cellona RV, Palmer JP, Wittes J, Thomas SD, Kook KA, Walsh GP, Walsh DS. Am J Trop Med Hyg; 2005 May; 72(5):518-26. PubMed ID: 15891124 [Abstract] [Full Text] [Related]
13. Deep vein thrombosis: a rare complication of thalidomide therapy in recurrent erythema nodosum leprosum. Sharma NL, Sharma V, Shanker V, Mahajan VK, Sarin S. Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):483-5. PubMed ID: 15755204 [Abstract] [Full Text] [Related]
14. Double-blind trial of the efficacy of pentoxifylline vs thalidomide for the treatment of type II reaction in leprosy. Sales AM, de Matos HJ, Nery JA, Duppre NC, Sampaio EP, Sarno EN. Braz J Med Biol Res; 2007 Feb; 40(2):243-8. PubMed ID: 17273661 [Abstract] [Full Text] [Related]
16. [Japanese guideline on thalidomide usage in the management of erythema nodosum leprosum]. Ishii N, Ishida Y, Okano Y, Ozaki M, Gidoh M, Kumano K, Goto M, Nogami R, Hatano K, Yamada A, Yotsu RR. Nihon Hansenbyo Gakkai Zasshi; 2011 Sep; 80(3):275-85. PubMed ID: 21941834 [Abstract] [Full Text] [Related]
19. Frequency of thromboembolic events associated with thalidomide in the non-cancer setting: a case report and review of the literature. Fabi SG, Hill C, Witherspoon JN, Boone SL, West DP. J Drugs Dermatol; 2009 Aug; 8(8):765-9. PubMed ID: 19663116 [Abstract] [Full Text] [Related]